about
Heme oxygenase-1 induction improves cardiac function following myocardial ischemia by reducing oxidative stressCytochrome P-450 4A isoform expression and 20-HETE synthesis in renal preglomerular arteriesPromoter activity and regulation of the corneal CYP4B1 gene by hypoxia.Transfection of CYP4A1 cDNA decreases diameter and increases responsiveness of gracilis muscle arterioles to constrictor stimuli.Vascular CO counterbalances the sensitizing influence of 20-HETE on agonist-induced vasoconstriction.Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemiaBiliverdin Rescues the HO-2 Null Mouse Phenotype of Unresolved Chronic Inflammation Following Corneal Epithelial Injury.Heme oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative responseThe T8590C polymorphism of CYP4A11 and 20-hydroxyeicosatetraenoic acid in essential hypertension.Exacerbated corneal inflammation and neovascularization in the HO-2 null mice is ameliorated by biliverdinEndothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE.20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells.Retinoic acid induces corneal epithelial CYP4B1 gene expression and stimulates the synthesis of inflammatory 12-hydroxyeicosanoids.Endothelial progenitor cell function inversely correlates with long-term glucose control in diabetic patients: association with the attenuation of the heme oxygenase-adiponectin axisSmooth muscle--specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels.Renal 20-hydroxyeicosatetraenoic acid synthesis during pregnancy.Regulation of cyclooxygenase- and cytochrome p450-derived eicosanoids by heme oxygenase in the rat kidney.Transfection of CYP4A1 cDNA increases vascular reactivity in renal interlobar arteries.Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic Acid in human salt-sensitive versus salt-resistant hypertension.20-HETE and furosemide-induced natriuresis in salt-sensitive essential hypertension.Regulation of renal CYP4A expression and 20-HETE synthesis by nitric oxide in pregnant rats.Cytochrome P450-derived eicosanoids mediators of ocular surface inflammation. are.20-HETE and circulating insulin in essential hypertension with obesity.Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.Heme oxygenase-1 gene expression modulates angiotensin II-induced increase in blood pressure.Transfection and functional expression of CYP4A1 and CYP4A2 using bicistronic vectors in vascular cells and tissues.Decreased levels of cytochrome P450 2E1-derived eicosanoids sensitize renal arteries to constrictor agonists in spontaneously hypertensive rats.Transfection of cytochrome P4504B1 into the cornea increases angiogenic activity of the limbal vessels.Cytochrome P450 4A isoform inhibitory profile of N-hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine (HET0016), a selective inhibitor of 20-HETE synthesis.Two Pools of Epoxyeicosatrienoic Acids in Humans: Alterations in Salt-Sensitive Normotensive Subjects.
P50
Q28541319-C048E368-227E-4FE0-89DC-29EA10994624Q28574070-A00694A7-AC89-42DD-91EE-D7449AA38DD9Q33200408-D14A13CC-25BD-4A2D-8A18-01791582FEFCQ34319201-8C6544CF-3FCC-4C15-A0C0-6094EC364645Q34330134-D05A0B4A-FF0A-4B37-9C7A-2977939DC6B7Q34938962-EE7FA6D5-AFB7-450B-AB76-FCA1A8E0BF61Q35027550-AA080D46-94E4-4D0C-B22C-A1C8C4AA0553Q35607392-68285287-6CAF-4A09-8382-AF00A2FB916BQ36628304-609E352D-9AE3-4B95-8414-59598035F9ADQ37066708-0AE57C36-1539-4E8B-919A-8876DF74E08EQ37417272-E924177F-F063-4560-9B04-B3B17CFD4D43Q40065601-36720334-2F6B-4649-B125-9BD2C8B7EDA6Q40581235-D241645E-24B9-4FFA-BD5E-9D06AB274DA1Q41375355-434286C8-5C2D-4EF2-854B-CA0165EAB987Q42833184-8C08E1FA-D706-458F-9A63-06BE2420B020Q43855638-32214AC6-1B36-43B6-A86F-4CAEC8C3F816Q43908284-53AC1617-BFE9-4A59-8B8E-51C4ECCF199BQ44185776-ABC5E8C6-9045-4379-9867-BEB32B124842Q44302079-8DA69E4E-169D-4D1C-B21A-99D38C6000A0Q44353820-0058FC16-26D3-42F2-A9C6-0C484558424EQ44396063-0C07227D-34C9-4CB5-AB7F-6B404610A9EAQ44443971-11234E15-AEE7-4179-BDDF-1B17B686C67CQ44715080-2AA981CE-7672-4ED3-9024-B53F48C5987AQ44739223-48DDA656-A42F-4FF2-8B50-99ABCB21B00FQ44912886-77AC25B9-7798-409C-B13E-92A61D136239Q44989764-AA1202C2-A424-42C4-822C-6A9A1DE022C7Q45166652-1AD42628-DCCE-4161-AB53-35E3B1BCA192Q46595075-8A7AD7ED-79BF-4024-8852-C7A2F340E047Q46686229-5D4D0C7F-A125-48E1-ABEB-45DAB8BD30B4Q47246584-A12A6721-1421-42EA-80D0-982340F859D2
P50
name
Michal Laniado-Schwartzman
@ast
Michal Laniado-Schwartzman
@en
Michal Laniado-Schwartzman
@es
Michal Laniado-Schwartzman
@nl
type
label
Michal Laniado-Schwartzman
@ast
Michal Laniado-Schwartzman
@en
Michal Laniado-Schwartzman
@es
Michal Laniado-Schwartzman
@nl
prefLabel
Michal Laniado-Schwartzman
@ast
Michal Laniado-Schwartzman
@en
Michal Laniado-Schwartzman
@es
Michal Laniado-Schwartzman
@nl